Assessment and optimization of Theileria parva sporozoite fulllength p67 antigen expression in mammalian cells
Delivery of various forms of recombinant Theileria parva sporozoite antigen (p67) has been shown to elicit antibody responses in cattle capable of providing protection against East Coast fever, the clinical disease caused by T. parva. Previous formulations of full-length and shorter recombinant vers...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Journal Article |
| Language: | Inglés |
| Published: |
Public Library of Science
2017
|
| Subjects: | |
| Online Access: | https://hdl.handle.net/10568/99702 |
Similar Items: Assessment and optimization of Theileria parva sporozoite fulllength p67 antigen expression in mammalian cells
- Experiences with immunization against Theileria parva using p67, a sporozoite surface antigen
- Fusion to green fluorescent protein improves expression levels of Theileria parva sporozoite surface antigen p67 in insect cells
- Synergistic effect of two nanotechnologies enhances the protective capacity of the Theileria parva sporozoite p67C antigen in cattle
- Bovine Herpesvirus-4 as a delivery platform for Theileria parva antigens
- Selection of T. parva CD4+ T-cell Candidate Antigens and T. parva Immunopathogy
- Nanoparticle platform to fight old foes. T. parva p67C antigen as a model